5BAKER J F,KRISHNAN E,CHEN L,et al.Serum uric acid and cardiovascular disease:recent developments,and where do they leave us[J].Am J Med,2005,118(8):816-826.
6CHIEN K L,HSU H C,SUNG F C,et al.Hyperuricemia as a risk factor on cardiovascular events in Taiwan:The Chin-Shan Community Cardiovascular Cohort Study[J].Atherosclerosis,2005,183(1):147-155.
7CHEN H Z.Practice of Internal Medicine(实用内科学)[M].Beijing:People's Medical Publishing House,2005:2602-2609.
8MASSEOU D,ROTT K,LIU-BRYAN R,et al.Overview of hyperuricaemia and gout[J].Curr Pharm Des,2005,11(32):4117-4124.
9WORTMANN R L.Recent advances in the management of gout and hyperuricemia[J].Curr Opin Rheumatol,2005,17(3):319-324.
10BRAND N,MCGEE D L,KANNEL W B,et al.Hyperuricemia as a risk factor of coronary heart disease:The Framingham Study[J].Am J Epidemiol,1985,121(1):11-18.
8Serby JV, Friedman GD, Quesenberry Cp Jr, et al.Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries[J]. Am J Epidemiol, 1990, 131: 1017- 1027.
9Mancia G,Fagard R, Narkiewicz K, et al. 2013ESH/ ESC guidelines for the management of arterial hyper- tension:the task force {or the management of arterial hypertension of the European Society of Hyperten- sion(ESH)and of the European Society of Cardiology (ESC)[J]. Eur Heart J,2013,34(31):1281-1357.
10Neutel JM. The role of combination therapy in the management of hypertension [J ]. Nephro Dial Transplant, 2006,21 (6) : 1469 - 1473.
